Dr. Spitzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Zero Emerson Place Suite 118
Boston, MA 02114Phone+1 617-724-1124Fax+1 617-724-1126
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1983
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
University of Rochester School of Medicine and DentistryClass of 1974
Certifications & Licensure
MA State Medical License 1977 - 2026
OH State Medical License 1978 - 2026
NY State Medical License 1975 - 2025
DC State Medical License 1988 - 2001- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure Start of enrollment: 2003 Jun 01
- Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies Start of enrollment: 2002 Nov 01
- Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies Start of enrollment: 2004 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 29 citationsImproved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern YearsAreej El-Jawahri, Shuli Li, Joseph H. Antin, Thomas R. Spitzer, Philippe Armand
Biology of Blood and Marrow Transplantation. 2016-05-01 - 297 citationsIncreasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He
Biology of Blood and Marrow Transplantation. 2015-02-01 - 216 citationsMulti-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response withou...Paul G. Richardson, Carol S. Murakami, Zhezhen Jin, Diane Warren, Parisa Momtaz
Blood. 2002-12-15
Journal Articles
- Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated DonorsParameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Abstracts/Posters
- Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic DiseasesThomas Spitzer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T CellsThomas Spitzer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Three Kids Are Thriving After Kidney Transplants with No ImmunosuppressantsJune 27th, 2022- Ingenious Technique Leads to Kids Having Kidney Transplants Without Immune SuppressionJune 17th, 2022
- Transplant Success Without Immune Suppressive DrugsJune 16th, 2022
- Join now to see all
Grant Support
- Mixed Chimerism Following BMT For Hematologic MalignancyNational Cancer Institute2000–2002
- IL 2 In HLA Mismatched Bone Marrow TransplantationNational Cancer Institute1994–1997
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
